CTLA4 and rheumatoid arthritis: Notably, augmenting CTLA-4 function by infusing the recombinant soluble form of CTLA-4 called CTLA4-Ig (or abatacept) selectively inhibits T-cell co-stimulation and is beneficial for treating some autoimmune diseases, notably rheumatoid arthritis [14].